The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

MEFAC 250 mg Hard Capsules

Rowa Pharmaceuticals LimitedPA0074/015/001

Main Information

Trade NameMEFAC 250 mg Hard Capsules
Active SubstancesMefenamic acid
Dosage FormCapsule, hard
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/015/001

Group Information

ATC CodeM01AG Fenamates
M01AG01 mefenamic acid


License statusAuthorised
Licence Issued28/04/1988
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back